BlossomHill Therapeutics logo

BlossomHill Therapeutics Funding & Investors

BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.

bhtherapeutics.com

Total Amount Raised: $71,000,000

BlossomHill Therapeutics Funding Rounds

  • Series A

    $71,000,000

    Series A Investors

    Vivo Capital
    Cormorant Asset Management
    Hercules Bioventure Partners
    OrbiMed Advisors
Funding info provided by Diffbot.